A pioneering clinical trial has successfully enabled two patients with end-stage kidney disease to receive previously improbable kidney transplants. These individuals were considered among the most difficult in the nation to match with a compatible donor kidney due to harmful antibodies they had developed ("sensitized").
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗